In this study, PSP not only reduced the expression of EGFR but also promoted the death of colorectal cancer cells through the EGFR pathway in colorectal cancer cells, indicating that PSP has significant potential as a PD-L1 inhibitor and an immunological supplement in the treatment of CRC. The gene discussed is CD274; the disease is colorectal carcinoma.